Selective denervation with botulinus toxin as a therapeutic principle for some gastrointestinal diseases;Selektive denervierung durch botulinus-toxin als therapeutisches prinzip im gastrointestinaltrakt

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 7, 1999, Pages 197-203

  Schmitt, Th ^a   Wehrmann, T ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CONSTIPATION; DENERVATION; DRUG EFFICACY; ENDOSCOPIC SPHINCTEROTOMY; ESOPHAGUS ACHALASIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; LOWER ESOPHAGUS SPHINCTER; ODDI SPHINCTER; POSTOPERATIVE COMPLICATION; REVIEW; TREATMENT INDICATION;

EID: 0033582775     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024273     Document Type: Review

References (65)

1. 1 Albanese, A., G. Maria et al.: Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov. Disord. 5 (1997), 764-766.
2. 2 Annese, V., F. Basciani, F. Perri et al.: Controlled trial of botulinum toxin injection versus placebo and pneumatic dilatation in achalasia. Gastroenterology 111 (1996), 1418-1424.
3. 3 Arabi, Y., J. Alexander-Williams, M. R. B. Keighley: Anal pressure in hemorrhoids and anal fissure. Ann. J. Surg. 134 (1977), 608-610.
4. 4 Bansal, R., J. M. Scheiman, J. L. Barnett, G. H. Elta, T. T. Nostrant: Intrasphinteric injection of botulinum toxin for achalasia. Gastroenterology 108 (1995), A 54 (Abstract).
5. 5 Birgisson, S., J. E. Richter: Longterm outcome of botulinum toxin in the treatment of achalasia. Gastroenterology 111 (1996), 1162.
6. 6 Botoman, V. A., R. A. Kozarek, L. A. Novell: Long term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest. Endosc. 40 (1994), 165-170.
7. 7 Bozkurt, T., K. H. Orth, B. Butsch, G. Lux: Long term clinical outcome of post-cholecystectomy patients with biliary type pain. Europ. J. Gastroenterol. Hepatol. 8 (1996), 245-249.
8. 8 Cassidy, M. J., T. D. Schiano et al.: Botulinum toxin injection for the treatment of symptomatic diffuse esophageal spasm. Amer. J. Gastroenterol. 91 (1996), 1884 (abstract).
9. 9 Chen, Y. K., R. L. Foliente, M. Santorno, M. H. Walter, M. J. Collen: Endoscopic sphincterotomy-induced pancreatitis. Amer. J. Gastroenterol. 89 (1994), 327-333.
10. 10 Connors, P.J., L. S. Friedman: Pancreas divisum: to stent or not to stent. Gastroenterology 104 (1993), 1226-1228.
11. 11 Cuilliere, C., P. Ducrotte, F. Zerbib et al.: Achalasia outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 41 (1997), 87-92.
12. 12 Eaker, E. Y., J. M. Gordon, S. B. Vogel: Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig. Dis. Sci. 42 (1997), 724-727.
13. 13 Fishman, V. M., H. P. Parkman et al.: Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Amer. J. Gastroenterol. 91 (1996), 1724-1730.
14. 14 Freeman, M. L., D. B. Nelson et al.: Complications of endoscopic biliary sphincterotomy. New Engl. J. Med. 335 (1996), 909-918.
15. 15 Cullarton, G. M., W. R. Murray: Evaluation of endoscopic sphincterotomy in sphincter of Oddi dysfunction. Endoscopy 24 (1992), 199-202.
16. 16 Geenen, J. E., W. J. Hogan et al.: The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. New Engl. J. Med. 320 (1989), 82-87.
17. 17 Gibbons, C. P., N. W. Read: Anal hypertonia in fissures: cause of effect? Brit. J. Surg. 73 (1986), 443-445.
18. 18 Gordon, J. M., E. Y. Eaker: Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Amer. Gastroenterol. 10 (1997), 1812-1817.
19. 19 Greaves, R. R. H. E. Mulcahy et al.: Botulinum toxin in the treatment of achalasia. A promise unfulfilled. Gastroenterology 110 (1996), A 123 (abstract).
20. 20 Hallan, R. I. et al.: Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 2 (1988), 714-717.
21. 21 Hogan, W. J., J. E. Geenen: Biliary dyskinesia. Endoscopy 20 (1988), 179-184.
22. 22 Jankovic, J., M. F. Brin: Therapeutic uses of botulinum toxin. New Engl. J. Med. 324 (1991), 1186-1195.
23. 23 Jin, H. O., G. D. Potter, A. N. Shah, V. F. Ona, M. Malkin, W. Y. Chey: Effect of intrasphincteric injection of botulinum toxin on esophageal motility in achalasia. Gastroenterology 108 (1995), A 123 (abstract).
24. 24 Jost, W. H.: One hundred cases of chronic anal fissure treated with botulinum toxin. Dis. Colon Rec. 40 (1997), 1029-1032.
25. 25 Joo, J. S., F. Agachan, B. Wolff, J. J. Nogueras, S. D. Wexner: Initial North American experience with botulinum toxin type A for treatment of anismus. Dis. Colon Rec. 39 (1996), 1107-1111.
26. 26 Kozarek, R. A., T. J. Ball et al.: Endoscopic approach to pancreas divisum. Dig. Dis. Sci. 40 (1995), 1974-1981.
27. 27 Kumar, D., S. Rathgeber, N. Atherly: Endoscopic sphincterotomy in post-cholezystectomized patients with type III - sphincter of Oddi dysfunction. Gastrointest. Endosc. 38 (1992), 255 (abstract).
28. 28 Lans, J. I., J. E. Geenen: Endoscopic therapy in patients with pancreas divisum and acute pancreatitis. Gastrointest. Endosc. 38 (1992), 430-434.
29. 29 Lehman, G. A., S. Sherman, R. Nisi, R. H. Hawes: Pancreas divisum. Gastrointest. Endosc. 39 (1993), 1-8.
30. 30 Lund, J. N. et al.: Use of glyceryl trinitrate ointment in the treatment of anal fissure. Brit. J. Surg. 83 (1996), 776-777.
31. 31 Maria, G., E. Casseta, D. Gui, G. Brisinida, E. R. Bentivoglio, A. Albanese: A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. New Engl. J. Med. 338 (1998), 217-220.
32. 32 Mason, P. F., M. J. Watkins, H. S. Hall, A. W. Hall: The management of chronic fissure in ano with botulinum toxin. J. roy. Coll. Surg. Edinburgh 41 (1996), 235-238.
33. 33 MacKenzie, J., G. Burnstock, J. O. Dolly: The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropin-resistant autonomic neuromuscular transmission. Neuroscience 7 (1982), 997-1006.
34. 34 Miller, L. S., H. P. Parkman et al.: Treatment of symptomatic nonachalasia esophageal motility disorders with botulinum toxin injection at the lower esophageal sphincter. Dig. Dis. Sci. 41 (1996), 2025-2031.
35. 35 Montecucco, C., G. Schiavo: Mechanism of action of tetanus and botulinum neurotoxins. Molec. Microbiol. 13 (1994), 1-8.
36. 36 Muehldorfer, S. M., E. G. Hahn, C. Ell: Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis. Endoscopy 29 (1997), 120-124.
37. 37 National Institute of Health. Consensus conference November 1990. Clinical use of botulinum toxin. Connecticut Med. 55 (1991 ), 471.
38. 38 Notham, B. J., M. M. Schuster: Internal anal sphincter derangment with anal fissure. Gastroenterology 67 (1974), 216-230.
39. 39 Pasricha, P. J., W. J. Ravich, A. N. Kalloo: Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105 (1993), 1045-1049.
40. 40 Pasricha, P. J., W. J. Ravich, T. R. Hendrix, S. Sostre, B. Jones, A. N. Kalloo: Treatment of achalasia with intrasphincteric injection of botulinum toxin. Ann. intern. Med. 121 (1994), 590-591.
41. 41 Pasricha, P. J., E. P. Miskovsky, A. N. Kalloo: Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 35 (1994), 1319-1321.
42. 42 Pasricha, P. J., W. J. Ravich, T. R. Hendrix, S. Sostre, B. Jones, A. N. Kalloo: Intrasphincteric botulinum toxin for the treatment of achalasia. New Engl. J. Med. 322 (1995), 774-778.
43. 43 Pasricha, P. J., R. Rai, W. J. Ravich, T. R. Hendrix, A. N. Kalloo: Botulinum toxin for achalasia. Gastroenterology 110 (1996), 1410-1415.
44. 44 Panaccione, R., J. C. Gregor, R. P. E. Reynolds, H. G. Preiksaitis: A cost minimization analysis of intrasphincteric botulinum toxin versus pneumatic dilatation in patients with achalasia. Gastroenterology 112 (1997), A 250 (abstract).
45. 45 Rollan, A., R. Gonzalez, S. Carvajal, J. Chianale: Endoscopic intrasphincteric injection of botulinum toxin for the treatment of achalasia. J. clin. Gastroenterol. 20 (1995), 189-191.
46. 46 Rolny, P., J. E. Geenen, W. Hogan: Post-cholecystectomy patients with objective signs of partial bile outflow obstruction. Gastrointest. Endosc. 39 (1993), 778-781.
47. 47 Russel, R. C., N. W. Wong, P. B. Cotton: Accessory sphincterotomy (endoscopic and surgical) in patients with pancreas divisum. Brit. J. Surg. 71 (1992), 954-957.
48. 48 Schwartz, K. S., J. Jankovic: Predicting the response to botulinum toxin injections for treatment of cervical dystonia. Neurology 40, Suppl. 1: (1990), 382 (abstract).
49. 49 Schwartz, H. M., C. E. Cahow, M. Traube: Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig. Dis. Sci. 38 (1993), 1409-1413.
50. 50 Scott, A. B.: Botulinum toxin injections into extraocular muscles as an alternative to strabismus surgery. Ophtalmology 87 (1980), 1044-1049.
51. 51 Simpson, L. L: The origin, structure, and pharmacologic activity of botulinum toxin. Pharmacol. Rev. 33 (1981), 155-188.
52. 52 Sherman, S., T. A. Ruffolo et al.: Complications of endoscopic sphincterotomy. Gastroenterology 101 (1991), 1068-1075.
53. 53 Vallera, R. A., S. R. Brazer: Botulinum toxin for suspected pseudoachalasia. Amer. J. Gastroenterol. 90 (1995), 1319-1321.
54. 54 Vantrappen, G., J. Hellemans: Treatment of achalasia and related motor disorders. Gastroenterology 79 (1980), 144-154.
55. 55 Warshaw, A. L., J. M. Richter, R. H. Schapiro: The cause and treatment of pancreatitis associated with pancreas divisum. Ann. Surg. 198 (1983), 443-452.
56. 56 Waterfall, W. E., G. Tougas, B. Fachinie, U. Chauhan: Gastroenterology 108 (1995), A 255 (abstract).
57. 57 Watson, S.J., M. A. Kamm et al.:Topical glyceryl trinitrate in the treatment of chronic anal fissure. Brit. J. Surg. 83 (1996), 771-775.
58. 58 Wehrmann, T., K. Wiener, B. Lembcke, M. Jung: Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis. Z. Gastroenterol. 33 (1995), 662-668.
59. 59 Wehrmann, T., V. Jacobi, M. Jung, B. Lembcke, W. F. Caspary: Pneumatic dilation in achalasia with a low-compliance balloon. Gastrointest. Endosc. 1 (1995), 31-36.
60. 60 Wehrmann, T., K. Wiemer, B. Lembcke, W. F. Caspary, M. Jung: Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? Europ. J. Gastroenterol. Hepatol. 8 (1996), 251-256.
61. 61 Wehrmann. T., O. G. Wendler, M. Jung, W. F. Caspary: Risikofaktoren der endoskopischen Manometrie bei Verdacht auf Sphinkter-Oddi-Dysfunktion. Dtsch. med. Wschr. 122 (1997), 808-814.
62. 62 Wehrmann, T., H. Seifert, M. Seipp, B. Lembcke, W. F. Caspary: Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 30 (1998), 702-707.
63. 64 Wehrmann, T., H. Kokabpick, H. Seifert, W. F. Caspary: Endoskopische Botulinus-Toxin Injektion bei Hochrisiko-Achalasie-Patienten. Z. Gastroenterol. 36 (1998), 726 (abstract).
64. 65 Wiegand, H., H. H. Wellhorner: The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Arch. Pharmacol. 292 (1976), 161-165.
65. 66 Wiesel, P. H., R. Schneider, G. Dorta et al.: Botulinum toxin for refractory postoperative pyloric spasm. Endoscopy 29 (1997), 132.